Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $689,899 - $805,647
4,457 New
4,457 $764,000
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $478,435 - $538,830
3,477 New
3,477 $539,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Gunn & CO Investment Management, Inc. Portfolio

Follow Gunn & CO Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gunn & CO Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gunn & CO Investment Management, Inc. with notifications on news.